Abbott Labs To Buy Russia's Veropharm For More Than $530 Million
This article was originally published in PharmAsia News
Executive Summary
Abbott Laboratories and Veropharm have agreed to a non-hostile buyout of the Russia drug maker for more than $530 million, Abbott gaining about 100 drugs in the process.